Proteome Sciences plc
PRM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £10,036 | £13,335 | £10,787 | £18,543 |
| - Cash | £1,128 | £2,027 | £3,994 | £2,387 |
| + Debt | £14,522 | £13,475 | £11,915 | £11,687 |
| Enterprise Value | £23,430 | £24,783 | £18,708 | £27,843 |
| Revenue | £4,887 | £5,028 | £23,736,000 | £22,593,000 |
| % Growth | -2.8% | -100% | 5.1% | – |
| Gross Profit | £670 | £1,647 | £4,767 | £2,960 |
| % Margin | 13.7% | 32.8% | 0% | 0% |
| EBITDA | -£1,515 | -£1,137 | £2,125 | £625 |
| % Margin | -31% | -22.6% | 0% | 0% |
| Net Income | -£3,406 | -£2,443 | £1,325 | £72 |
| % Margin | -69.7% | -48.6% | 0% | 0% |
| EPS Diluted | -0.012 | -0.008 | 0.004 | 0 |
| % Growth | -38.6% | -293% | 2,050% | – |
| Operating Cash Flow | -£826 | -£481 | £3,882,000 | £10,522,000 |
| Capital Expenditures | -£224 | -£237 | -£1,746,000 | -£1,720,000 |
| Free Cash Flow | -£1,050 | -£718 | £2,136,000 | £8,802,000 |